Viking Therapeutics (VKTX) deemed 'extremely attractive' and undervalued by Canaccord, cited as leader in obesity clinical development

Viking Therapeutics Inc. (NASDAQ:VKTX) is one of the stocks that will double in 2026. Earlier on November 12, Canaccord ...

Why gout cases are rising explained: Simple lifestyle changes to lower uric acid risk

Gout, a painful joint condition, is on the rise globally, affecting even younger individuals. This surge is linked to ageing ...

MBX Biosciences (MBX) faces platform validation challenge as near-term hypoglycemia data catalyst in Q2 2026 may lack differentiation

MBX Biosciences Inc. (NASDAQ:MBX) is one of the stocks that will double in 2026. On December 4, Goldman Sachs initiated ...